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Abstract 
 Hypertension is an elevation of  systolic blood pressure (SBP) ≥140 mm Hg, or a diastolic blood 
pressure (DBP) ≥90 mm Hg, or using antihypertensive drugs. Arterial hypertension causes high 
morbidity and mortality because its harmful impact on many systems, especially the cardiovascular 
system. Despite good control of their blood pressure, young patients with non-complicated hypertension 
are usually presented with exercise intolerance which necessitate the search for possible causes. Aim: 
The present study is targeted to discover possible subtle systolic dysfunction and its correlation with 
exercise capacity among young age patients with chronic non complicated hypertension as well as to 
assign the main factors affecting exercise capacity in those patients. Methods: A total of 80 young age 
participants involved in this study. They are grouped as a group I (control subjects) , n= 40 (female: 17, 
male: 23) and group II (hypertensive patients), n= 40 (male: 27, female: 13) with different BMI levels. 
Group II further subdivided into group A (exercise capacity > 7 MET) and B (exercise capacity≤7 MET). 
Strain analysis was performed using propriety software on the echocardiograph. TDI and PWD are used 
to measure E/e, and PCWP. All participants are subjected to treadmill test using Bruce protocol in order 
to obtain exercise capacity and to exclude IHD. Results: Compared to normal subjects, non-complicated 
hypertensive patients have significantly reduced GLS (P value: 0.00) and increased PSI (P value: 0.00) 
as well as a significant increase in E/e, (P value: 0.00), PCWP (P value: 0.00) and a significant reduction 
in exercise capacity (P value: 0.00). In hypertensive patients with exercise capacity ≤7 MET versus those 
with exercise capacity >7 MET, there is no statistical difference between the average GLS (P value:0.6), 
average PSI (P value: 0.07) while significant elevation of E/e, (P value: 0.01) and PCWP (P value: 0.01) 
are observed in hypertensive patients with lower exercise capacity. Conclusion: Though significant 
changes in GLS, PSI and lower exercise capacity are evident in hypertensive patients in relation to 
healthy control subjects, Low exercise capacity in those patients is related to significant diastolic changes 
rather than subclinical systolic dysfunction. 
Key words: Hypertension, exercise capacity, global longitudinal strain, post systolic shortening index, 
pulmonary capillary wedge pressure, E/e,, treadmill test. 
Abbreviations: SBP: systolic blood pressure, DBP: diastolic blood pressure, MET: 
metabolic equivalent of O2 consumption, BMI: body mass index, PCWP: Pulmonary 
capillary wedge pressure, IHD: ischemic heart disease, GLSP: Global longitudinal 
strain, PSI: Post-systolic index.  
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Introduction 
Hypertension is an elevation of  systolic blood pressure (SBP) ≥ 140 mm Hg, or 
a diastolic blood pressure (DBP) ≥ 90 mm Hg, or using antihypertensive drugs 
regardless the current blood pressure level.(1) Arterial hypertension causes high 
morbidity and mortality because its harmful impact on many systems, specially the 
cardiovascular system.(2) Before functional changes in the heart of hypertensive patient 
become apparent, there will be  a progressive myocardial fibrosis and abnormal  left 
ventricular (LV) geometry.(3)  Diastolic impairment is major portion of this pathology, 
and in spite of the developing fact of its significance, it is largely underestimated awing 
to its difficult diagnosis as well as the absence  of effective treatments.(4)  Many 
researchers reported that despite the presence of normal systolic function as evident by 
ejection fraction or fractional shortening, abnormalities of diastolic indices may occur, 
giving the idea that diastolic dysfunction may go before or independent of systolic 
dysfunction. (5) Nevertheless, in all reports that study this topic, systolic function was 
assessed at the endocardium level, indicating a chamber function of LV, which is a 
physiological result of the interaction between myocardial function and geometry of  
left ventricle.(6) Additionally, while ordinary echocardiogram can identify variations in 
LV diastolic abnormalities related to left ventricle hypertrophy. LV systolic function is 
protected until late in the progression of the disease, making subtle changes in left 
ventricle contractile function troublesome to assess in the initial stages.(7) Subclinical 
alterations in left ventricle function can be distinguished by evaluating strain of 
myocardial tissue, a dimensionless estimation of deformation. Two-dimensional (2D) 
speckle tracking nowadays  has a new echocardiographic approach for quick 
examination of left ventricle strains of the longitudinal, circumferential and radial 
fibers. This strategy evaluates myocardial movement by tracking natural acoustic 
reflections and interference patterns seen in two-dimensional echocardiographic 
pictures and has been approved with estimations gotten by MRI and sonomicrometry.(8) 
On the other hand, post-systolic shortening (PSS) is a longitudinal shortening after 
aortic valve closure, is of particular interest since it indicates, with high sensitivity, 
regional abnormalities. A newly occurring PSS during a stress echo is always a marker 
of ischemia while pre-existing PSS is only then likely to be pathologic if systolic 
shortening is reduced and PSS exceed 20% of the total deformation amplitude. It can 
be used as a prognostic marker for arrhythmic events. (9) 
 
Methods 
A total of 80 young age individuals involved in this study. In order to exclude 
conditions that might affect our outcomes, the following criteria are required: 
a) No clinical evidence or previous history of IHD, valvular heart disease, diabetes 
mellitus, heart failure, respiratory disease and renal failure. 
b) Not athletic. 
c) Not smoker 
 
All subjects provided information on family history, personal habits (drug 
ingestion, level and type of physical exercise, known disease condition and alcohol 
intake).  
Those patients who are already diagnosed as having primary non complicated (no 
end organ damage) hypertension and taking single or combined antihypertensive 
medications (including ACEI, ARB, beta-blockers or CCB) are included in the study 
while those who have fluctuations in their blood pressure levels and do not take 
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antihypertensive medications are excluded from patients group to avoid selection bias. 
Duration of hypertension in months is documented for each patient. In our study we do 
not focus on statistical effect of treatment modality on study variables. The patients 
were grouped as a group I (control subjects) , n= 40 (female: 17, male: 23) and group 
II (hypertensive patients), n= 40 (male: 27, female: 13) with different BMI levels. In 
Further subsequent analysis, we exclude BMI ≥ 30 kg/m2 from group II in order to 
minimize the effect of BMI on the study results. In regard to group II, Since exercise 
capacity less than 7 MET is considered low (10), they are subdivided into two subgroups: 
those with exercise capacity >7 MET (n=22) and those with exercise capacity ≤7 MET 
(n=18).  
 
Echocardiography  
A complete two dimensional echocardiography is achieved in all patients, using a 
commercially available ultrasound transducer and equipment (M5sc probe, GE, Vivid 
E9, 2015, USA). All acquisitions were performed by the same operator with the patients 
in the left lateral position.  
 
E/e' calculation  
Measurement of pulsed-wave Doppler of the early (E), late (A) of mitral inflow 
velocities as well as deceleration time of early filling phase of left ventricle are carried 
out. Using tissue Doppler in the 4-chamber view, the peak early diastolic velocity of 
the lateral and medial mitral annulus (e′) are measured to obtain average E/e'. 
 
 
Figure 1 Calculation of E/e' ratio 
 
Pulmonary capillary wedge pressure (PCWP) is measured in an attempt to 
compare our results with hemodynamic impact of diastolic dysfunction resulting from 
hypertension 
PCWP= (E/e´ x 1.25) + 1.9 or simply 4+ E/e' (Nagueh Formula). (11)  
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Speckle tracking analysis  
Three apical views are used for the purpose of speckle tracking analysis (two-
champer, four-chamber, and long-axis). Three points on each view (the apex and two 
on each mitral annuli) are identified by the examiner. Peak systolic longitudinal strain 
in corresponding segments of every view along with defining an aortic valve closure 
is then identified by the software. Global longitudinal strain is obtained by taking the 
average strain for these three views (seventeen segments with six basal, six mid, four 
apical, and the one true apex). The frame rate is kept between 70 Hz and 100 Hz. The 
strain curve is extracted, the peak negative wave of strain during the whole cardiac 
cycle is referred as peak strain.(12) Post systolic index is simultaneously obtained from 
another map.  
 
Figure 2 Bulls-eye figure of peak systolic strain 
 
Treadmill test  
  All participants subjected to treadmill test using Bruce protocol in order to 
obtain exercise capacity and exclude the possibility of IHD. Our goal is to achieve 
maximal stress, i.e. when they reach ≥85% of their maximal predicted HR, which can 
be measured as 220-age for male and 210-age for female.(13) 
 
Results 
The mean values of the study groups (group I; control) and group II; hypertensive 
patients for GLS, PSI, E/e,, PCWP and exercise capacity at different and matched BMI 
are illustrated in Table 1 and 2. In our study, there is a significant difference in GLS (P 
value: 0.00) and PSI (P value:0.00), E/e (P value: 0.00), PCWP (P value: 0.00) and 
exercise capacity (P value: 0.00) between the two groups. Hypertensive patients showed 
significantly lower GLS and higher PSI as well as a significant increase in E/e and 
PCWP and lower exercise capacity at both different and matched BMI. 
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Table 1: the values of GLS, PSI, E/e, PCWP and exercise capacity, according to study 
groups at different BMI 
Data  
(M±SD) 
Group I 
N=40 (male:23, female: 17) 
      Age (23-37yr) 
      BMI (20.8-28.7) 
Group II 
N=40 (male:27,female: 13) 
       Age (20-40yr) 
       BMI (22.9-37) 
P value 
GLS (average) 
(%) 
-21.1±1.4 -18.7±2.6 0.000 
PSI (average) 
(%) 
0.92±0.36 3.4±2.07 0.000 
E/e, 4.3±1.01 7.71±2.31 0.000 
PCWP 
(mmHg) 
8.3±1.02 11.4±2.84 0.000 
Exercise 
capacity (MET) 
10.45±0.63 8.2±1.9 0.000 
Values presented as M±SD. GLS: global longitudinal strain, PSI: post systolic index, 
PCWP: pulmonary capillary wedge pressure, MET: metabolic oxygen equivalent   
Table 2 The values of GLS, PSI, E/e, PCWP and exercise capacity according to 
study groups with matched BMI 
 
Data  
(M±SD) 
 
Group I 
N=40 (male:23, female: 17) 
      Age (23-37yr) 
      BMI (20.8-28.7) 
 
Group II 
N=14 (male:10, female: 4) 
       Age (20-40yr) 
       BMI (22.9-37) 
 
P value 
GLS (average) (%) -21.1±1.4 -19.2±2.4 0.007 
PSI (average) 
(%) 
0.92±0.36 2.8±1.8 0.000 
E/e, 4.3±1.01 6.75±1.8 0.000 
PCWP 
(mmHg) 
8.3±1.02 10.2±2.23 0.003 
Exercise capacity 
(MET) 
10.45±0.63 8.6±2.07 0.001 
Values presented as M±SD. GLS: global longitudinal strain, PSI: post systolic index, 
PCWP: pulmonary capillary wedge pressure, MET: metabolic oxygen equivalent   
Statistical analysis of different echocardiographic parameters is then conducted 
in relation to exercise capacity in group II (hypertensive patients). Patients group is 
subdivided into two subgroups: those with exercise capacity >7 MET (n=22) and those 
with exercise capacity ≤7 MET (n=18).  In these two subgroups there is no statistical 
difference between the GLS (P value:0.6). Nevertheless higher PSI is documented in 
group B hypertensive patients with low exercise capacity, but statistically still not 
significant (P value: 0.07).  E/e, and PCWP are significantly elevated in patients with 
lower exercise capacity as shown in figure 1,2,3 and 4. 
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Figure 3: Average global longitudinal strain (GLS), (%) in group A (exercise 
capacity >7 MET, n:22) and group B (exercise capacity ≤7 MET, n:18) 
 
Figure 4:  Average post systolic index (PSI), (%) in group A (exercise capacity >7 
MET, n:22) and group B (exercise capacity ≤7 MET, n:18) 
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Figure 5:  E/e, ratio in group A (exercise capacity >7 MET, n:22) and group B 
(exercise capacity ≤7 MET, n:18) 
 
 
Figure 6:  Pulmonary capillary wedge pressure (PCWP), (mmHg) in group A 
(exercise capacity >7 MET, n:22) and group B (exercise capacity ≤7 MET, n:18) 
 
Discussion 
Hypertension is a common disease and has multiple effects on CVS, especially 
the heart, in our study the blood pressure was 137.7±15.5/86±13.4 mm Hg in non-
complicated hypertensive patients (all of them are receiving antihypertensive 
medications) and 119.3±18.5/75±11.4 mm Hg in normotensive control subjects. Body 
mass index is more in patients group (30.5±4.01kg/m2) compared to normotensive 
(24.9±2.2kg/m2) individuals. In our study at different BMI levels, hypertensive patients 
showed significantly lower global longitudinal strain and more post-systolic index, 
additionally, we demonstrated that there is significantly higher E/e and PCWP 
compared to normotensive individuals. These findings are consistent with a study by 
Shantanu P. et al, 2013(12) in which the shortening of longitudinal fiber was less in the 
patients with systemic hypertension and normal EF and FS than the corresponding 
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segments in the control group. The possible cause of reduced LV longitudinal strain in 
hypertensive individuals might be attributed to the existence of regional subendocardial 
ischemia and fibrosis of perivascular and interstitial regions.(14)  Myocardial post-
systolic shortening index has variable duration and amplitude in its characteristic 
waves. In one third of healthy individuals, post systolic contraction may occur in some 
myocardial segments and it is functionally not significant. On the other hand, post 
systolic contraction may indicates myocardial insults as ischemic damage together with 
abnormal strain. Post-systolic contraction takes place in an energetically demanding 
segments.(15) Asanuma et al. (16), showed that speckle tracking derived  PSI is the most 
useful echo parameters referring to myocardial injury during ischemia. In our patients 
PSI is significantly elevated, though in non-pathological limit indicated that serial 
subclinical myocardial changes has been occur in those patients group. Diastolic 
dysfunction is the main component of LV function that has been affected by systemic 
hypertension and it is independent of LV systolic function, namely you may found 
abnormal diastolic parameters with normal or supra-normal systolic function.(17) We 
approached the results of a study by Giovanni de S et al, 2000 who showed  that 
abnormal diastolic indices can be revealed in hypertensive patients in the presence of 
normal or supernormal systolic function.(17) We also showed significant increment in 
E/e, and PCWP and significant reduction in exercise capacity in hypertensive patients 
compared to control subjects with matched BMI. These results are approach to those 
groups of hypertensive patients with different BMI including obese subjects, indicated 
that these changes result mainly from hypertension effect. Diastolic function is an 
important factor in maintaining normal exercise capacity since it plays a major part in 
producing a maximal cardiac output. Throughout the exercise, the preservation of 
adequate left ventricular filling to safeguard a normal cardiac output comprises the 
capability to attain diastolic filling rates larger than the ejection rates during systole.(18) 
Though all of our patients are using antihypertensive medications with blood pressure 
level of (137.7±15.5/86±13.4 mmHg), but their exercise capacities of some what are 
still limited and well correlated with diastolic indices changes indicated that treatment 
may not influence exercise capacity, perhaps due to poor affection on diastolic function.  
Little W. et al, 2006 reported poor improvement in diastolic function in hypertensive 
subjects despite the use of effective anti-hypertensive drugs.(19) we disagree with 
Ljubica G et al (20) who showed that only lower GLS% appeared as an independent 
predictor of exercise capacity <7 METs while our study revealed no significant change 
in GLS. We postulate that antihypertensive medications may modulate systolic 
function, including GLS in both subgroups. 
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 الخلاصة
 ملم زئبق، أو ضغط الدم الانبساطي 041 ≥ )PBSارتفاع ضغط الدم هو ارتفاع في ضغط الدم الانقباضي ( 
، أو باستخدام الأدوية الخافضة لضغط الدم. ارتفاع ضغط الدم الشرياني يسبب ارتفاع معدلات المراضة والوفيات ملم زئبق 09≥ )PBD( 
تأثيره الضار على العديد من النظم ، وخاصة نظام القلب والأوعية الدموية. على الرغم من التحكم الجيد في ضغط الدم لديهم،  بسبب
فإن المرضى الصغار الذين يعانون من ارتفاع ضغط الدم غير المعقد عادًة ما يعانون من عدم تحمل التمرينات التي تستلزم البحث عن 
تهدف هذه الدراسة إلى اكتشاف الخلل الوظيفي الانقباضي الدقيق المحتمل وارتباطه بقدرة التمرين لدى صغار : هدفال الأسباب المحتملة.
السن المصابين بارتفاع ضغط الدم المزمن غير المعقد وكذلك تحديد العوامل الرئيسية التي تؤثر على قدرة التمرينات لدى هؤلاء 
من المشاركين في سن مبكرة المشاركة في هذه الدراسة. يتم تجميعها في المجموعة الأولى  08ما مجموعه : الأساليب المرضى.
 ) والمجموعة الثانية (مرضى ارتفاع ضغط الدم)، 32، ذكور:  71(أنثى:  04(الأشخاص الخاضعين للمراقبة)، ن = 
> لجسم. تنقسم المجموعة الثانية إلى المجموعة "أ" (قدرة التمرين) مع مستويات مختلفة من مؤشر كتلة ا31، أنثى:  72(ذكور:  04ن = 
تم إجراء تحليل الإجهاد باستخدام برنامج الحماية على مخطط صدى القلب. يتم  .)TEM 7 ≤قدرة التمرين ( B و )TEM 7
توكول بروس من أجل يتعرض جميع المشاركين لاختبار المطحنة باستخدام برو  .PWCP ، و e / E لقياس DWP و IDT استخدام
بالمقارنة مع الأشخاص الطبيعيين ، فإن : النتائج.  الحصول على القدرة على ممارسة الرياضة واستبعاد امراض اقفرار شرايين القلب
بالإضافة إلى زيادة  )00.0 :P قيمة( ISP وزادوا )00.0 :P قيمة( SLG مرضى ارتفاع ضغط الدم غير المعقد قد قللوا بشكل كبير
في مرضى  .)00.0 :P وانخفاض كبير في قدرة التمرين (قيمة )00.0 :P قيمة ( PWCP ، )00.0 :P ، (قيمة e / E ملحوظة في
، لا يوجد فرق إحصائي بين  TEM 7> مقابل أولئك الذين لديهم قدرة ممارسة TEM 7 ≤ارتفاع ضغط الدم الذين لديهم قدرة ممارسة 
 PWCP و )10.0 :P ، (قيمة e/E في حين يرتفع بشكل ملحوظ من )70.0 :P قيمة( ISP  سط، متو  )6.0 :P قيمة( SLG متوسط
لوحظت في مرضى ارتفاع ضغط الدم مع انخفاض القدرة على ممارسة الرياضة. الخلاصة: على الرغم من حدوث  )10.0 :P قيمة (
الرياضية لدى مرضى ارتفاع ضغط الدم فيما يتعلق بالمواضع وانخفاض القدرة على ممارسة التمرينات  ISP و SLG تغييرات كبيرة في
ة الكبيرة لمرضى يرتبط بالتغيرات الانبساطيالخاضعة للمراقبة الصحية ، إلا أن انخفاض القدرة على ممارسة التمرينات الرياضية لهؤلاء ا
 بدًلا من الخلل الوظيفي الانقباضي تحت الإكلينيكي.
 
